North America General Surgical Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.10 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America General Surgical Devices Market Analysis
The North America General Surgical Devices Market is expected to register a CAGR of 6.1% during the forecast period.
The COVID-19 pandemic adversely affected market growth. The impact was majorly associated with the restrictions on non-emergency surgical procedures during the pandemic. For instance, from the data from PubMed published in October 2021, it was observed that there has been a 42.8% decline in general surgery admission in North American countries such as the United States and Canada. Thus the general surgical devices market has been significantly impacted by COVID-19. However, currently, with the regularization of all the restrictions, the surgical procedure volume has reached pre-pandemic level which is fueling the market growth.
The key factors propelling the market growth in North America include rising demand for minimally invasive surgeries and growing accidents and injuries across the region. As per the American Academy of Orthopedic Surgeons (AAOS) Annual Report 2021, more than 2 million primary and revision hip and knee arthroplasty procedures were performed in the last decade. Primary knee (54.5%) and primary hip (38.6%) procedures made up most of the orthopedic surgeries in the country during the period. In addition, as per the American Joint Replacement Registry (AJRR) 2021, there were around 105,743 hip arthroplasty procedures for femoral neck fractures in the United States. Henceforth, the rising number of orthopedic surgical procedures is anticipated to support the market's growth in the United States.
Additionally, the data updated by Cedars-Sinai in January 2022 shows that coronary artery bypass graft surgery (CABG), also known as coronary artery bypass, or bypass surgery, is the most common heart surgery, and more than 300,000 people have successful bypass surgery in the United States each year. Further, the CDC data published in July 2022 indicated that coronary heart disease is the most common type of heart disease. Approximately 20.1 million adults of age 20 and older have the disease in the United States. As per the CDC data, every 40 seconds, someone suffers from a heart attack, and nearly 805,000 people in the United States have a heart attack every year. Thus, the high burden of cardiovascular diseases is expected to create demand for heart surgeries, further demanding the availability of surgical drills in healthcare settings. Hence, the increasing number of heart surgeries is predicted to fuel the market's growth during the forecast period in the country.
However, stringent government regulations and improper reimbursement for medical devices are some of the factors that are expected to restrain the market growth in the long run.
North America General Surgical Devices Market Trends
Orthopedic Segment is Expected to Witness a Strong Growth in Coming Years
The prevalence of diseases, such as osteoarthritis, has increased significantly in the North American region. For instance, according to a report, The Burden of Osteoarthritis in Canada (2021) commissioned by the Arthritis Community Research and Evaluation Unit (ACREU), around 15% of Canadians aged 20 years and above had osteoarthritis in 2021. The report stated that more than 4 million Canadians, or about 1 in every seven adults, have osteoarthritis in Canada. The high burden of such disorders is increasing the demand for orthopedic and trauma surgery in the country which is fueling the segment growth.
Additionally, New product launches in orthopedics are propelling the segment growth in the region. For instance, in October 2021, Medtronic Canada ULC announced the commercial launch of the Mazor X System for robotic-guided spine surgery. The Mazor platform offers a fully integrated procedural solution for surgical planning, workflow, execution, and confirmation, and is the first dedicated robotic-assisted spine surgery platform being launched in Canada.
Furthermore, in November 2021, Nova Scotia Health's QEII Health Sciences Centre received SmartRobotics system which is the second surgical robot of its kind in Canada. The innovative robotic arm is controlled by a surgeon during hip and knee surgeries and offers unprecedented precision for the placement of a joint implant (arthroplasty surgeries). Hence, owing to the increasing prevalence of orthopedic disorders and the new device launches, the segment is expected to witness a strong growth over the forecast period.
United States is Expected to Dominate the Market
In the North American region, the United States is the most developed country in terms of the healthcare sector. Due to the presence of key medical device providers and the high adoption of novel technologies in the country, the market studied is believed to witness significant growth.
The American Hospital Association (AHA)'s 'Fast Facts on US Hospitals, 2022' report indicated that the number of active hospitals in the United States increased from 5,534 in 2016 to 6093 in 2022. A steep rise in the volume of hospitals and increasing hospital admissions is expected to increase the surgical procedures and availability of devices used for the same. This is expected to drive the demand for the use of surgical devices for surgeries. This factor is expected to boost the market's growth.
Furthermore, market players are focusing on developing novel medical devices to satisfy users' needs. For instance, in October 2022, Olympus Corporation launched THUNDERBEAT(TM) Open Fine Jaw Type X surgical energy devices for open surgery in the United States. Additionally, in August 2021, Orthopaedic Implant Company announced the FDA clearance and commercially launched the DRPx System, a wrist fracture plating technology. The system features an enhanced ergonomic design to meet the technique preferences of orthopedic surgeons with a cost-effective approach. Moreover, according to WPLG INC, data published in May 2022, an estimated 900,000 knee replacements are performed annually in the United States.
Therefore, owing to the above-mentioned factors such as the increasing burden of disorders that require surgeries and the new product launches, the market studied is expected to witness strong growth over the forecast period.
North America General Surgical Devices Industry Overview
The North America General Surgical Devices Market is highly competitive because of the presence of many large, medium, and small players. Some of the major players in the market are B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, and Johnson & Johnson are among others.
North America General Surgical Devices Market Leaders
-
Medtronic PLC
-
B. Braun Melsungen AG
-
Cadence Inc.
-
Johnson & Johnson
-
Conmed Corporation
*Disclaimer: Major Players sorted in no particular order
North America General Surgical Devices Market News
- In August 2022, Teleflex signed up a contract to purchase Standard Bariatrics, a company that develops surgical staplers. Teleflex planned to buy the company for USD 170 million in cash upfront, with the potential for up to USD 130 million in additional payments after passing certain commercial milestones.
- In June 2022, Ethicon, Inc., a subsidiary of Johnson & Johnson, launched the next-gen Echelon 3000 stapler, a closure device for surgical procedures in the North American region.
North America General Surgical Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Demand for Minimally Invasive Devices
- 4.2.2 Growing Cases of Injuries and Accidents
-
4.3 Market Restraints
- 4.3.1 Stringent Government Regulations
- 4.3.2 Improper Reimbursement for Surgical Devices
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Handheld Devices
- 5.1.2 Laproscopic Devices
- 5.1.3 Electro Surgical Devices
- 5.1.4 Wound Closure Devices
- 5.1.5 Trocars and Access Devices
- 5.1.6 Other Products
-
5.2 By Application
- 5.2.1 Gynecology and Urology
- 5.2.2 Cardiology
- 5.2.3 Orthopaedic
- 5.2.4 Neurology
- 5.2.5 Other Applications
-
5.3 Geography
- 5.3.1 United States
- 5.3.2 Canada
- 5.3.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medtronic PLC
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Conmed Corporation
- 6.1.4 Boston Scientific Corporation
- 6.1.5 Johnson & Johnson
- 6.1.6 Olympus Corporations
- 6.1.7 Stryker Corporation
- 6.1.8 Integer Holdings Corporation
- 6.1.9 Cadence Inc.
- 6.1.10 Maquet Holding BV & Co. KG (Getinge AB)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
North America General Surgical Devices Industry Segmentation
As per the scope of the report, surgical devices serve a specific purpose during surgery. Typically, surgical devices have generic use, while some specific tools are designed for specific procedures or surgeries. The North America General Surgical Devices Market is Segmented by Product (Handheld Devices, Laparoscopic Devices, Electro Surgical Devices, Wound Closure Devices, Trocars, and Access Devices, and Other Products), Application (Gynecology and Urology, Cardiology, Orthopedic, Neurology, Other Applications) and Geography (United States, Canada, Mexico). The report offers the value (in USD million) for the above segments.
| By Product | Handheld Devices |
| Laproscopic Devices | |
| Electro Surgical Devices | |
| Wound Closure Devices | |
| Trocars and Access Devices | |
| Other Products | |
| By Application | Gynecology and Urology |
| Cardiology | |
| Orthopaedic | |
| Neurology | |
| Other Applications | |
| Geography | United States |
| Canada | |
| Mexico |
North America General Surgical Devices Market Research FAQs
What is the current North America General Surgical Devices Market size?
The North America General Surgical Devices Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)
Who are the key players in North America General Surgical Devices Market?
Medtronic PLC, B. Braun Melsungen AG, Cadence Inc., Johnson & Johnson and Conmed Corporation are the major companies operating in the North America General Surgical Devices Market.
What years does this North America General Surgical Devices Market cover?
The report covers the North America General Surgical Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America General Surgical Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America General Surgical Devices Industry Report
Statistics for the 2024 North America General Surgical Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America General Surgical Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
